介入和普通心脏病学杂志

Cardioversion Safety– Is It Safe To Say That We Are Doing Enough?

Abstract

Mohsen Khatami*, Marita Knudsen Pope, Sophie Le Page, Petra Radic, Valentina Schirripa, Irene Grundvold and Dan Atar

There is a significant periprocedural hazard of thromboembolic occasions in atrial fibrillation patients going through cardio-variant, and treatment with anticoagulants is accordingly a sign of cardioversion well being. In view of review sub-bunch examinations and imminent investigations, non-nutrient K enemies of coagulants are in any event as proficient as nutrient K-foes in forestalling thromboembolic intricacies after cardiovariant. The danger of thromboembolic intricacies after vehicle dioversion particularly relies upon the comorbidities in a given patient, and particularly cardiovascular breakdown, diabetes, and age. >75 years convey a uniquely expanded danger. Cardioversion has been viewed as protected inside a 48-h time window after beginning of atrial fibrillation without earlier treatment with anticoagulants, however late investigations have set this training into question dependent on for example flighty presentation appraisal of atrial fibrillation. Consequently, a straightforward and more functional methodology is here suggested, where early cardioversion is performed uniquely in haemodynamically temperamental patients.